• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin.血清和血浆因释放出一种类似胰激肽和缓激肽的物质而产生延迟性慢收缩效应。
Br J Pharmacol Chemother. 1956 Jun;11(2):111-8. doi: 10.1111/j.1476-5381.1956.tb01038.x.
2
A delayed, slow contracting effect of plasma and serum due to the formation of a substance resembling kallidin and bradykinin.由于形成了一种类似胰激肽和缓激肽的物质，血浆和血清产生延迟、缓慢的收缩效应。
J Physiol. 1955 Jul 28;129(1):30-1P.
3
A comparative study of kinin, kallidin, and bradykinin.激肽、胰激肽和缓激肽的比较研究。
Br J Pharmacol Chemother. 1957 Jun;12(2):149-58. doi: 10.1111/j.1476-5381.1957.tb00113.x.
4
A COMPARISON OF THE EFFECTS OF THE PLASMA KININS, BRADYKININ AND KALLIDIN, ON MYOCARDIAL BLOOD FLOW AND METABOLISM.血浆激肽（缓激肽和胰激肽）对心肌血流及代谢影响的比较
Br J Pharmacol Chemother. 1964 Feb;22(1):34-46. doi: 10.1111/j.1476-5381.1964.tb01541.x.
5
[STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P].[生物活性肽的结构与功能：缓激肽、胰激肽、血管紧张素和P物质]
Presse Med (1893). 1964 Oct 31;72:2693-8.
6
[Pharmacological differences between bradykinin and kallidin].[缓激肽与胰激肽的药理学差异]
Arch Int Pharmacodyn Ther. 1962 Nov 1;140:79-83.
7
THE EFFECT OF SOME PHYSIOLOGICAL VASODILATORS ON THE VASCULAR BED OF SKELETAL MUSCLE.某些生理性血管扩张剂对骨骼肌血管床的作用
Acta Physiol Scand. 1965 Jan-Feb;63:94-102. doi: 10.1111/j.1748-1716.1965.tb04046.x.
8
[EFFECT OF COCALNE ON THE ACTION OF DEPRESSOR-ACTIVE SUBSTANCE (DAS), BRADYKININ, KALLIDIN, HYPERTENSIN, HISTAMINE AND ACETYLCHOLINE].[可卡因对降压活性物质（DAS）、缓激肽、胰激肽、高血压素、组胺及乙酰胆碱作用的影响]
Med Exp Int J Exp Med. 1963;9:321-6.
9
BRADYKININOGEN, ANGIOTENSINOGEN AND KALLIDINOGEN.缓激肽原、血管紧张素原和胰激肽原。
Br J Pharmacol Chemother. 1963 Oct;21(2):250-8. doi: 10.1111/j.1476-5381.1963.tb01524.x.
10
NOCICEPTIVE RESPONSES OF GUINEA-PIGS TO INTRADERMAL INJECTIONS OF BRADYKININ AND KALLIDIN-10.豚鼠对皮内注射缓激肽和胰激肽-10的伤害性反应
Br J Pharmacol Chemother. 1963 Aug;21(1):155-64. doi: 10.1111/j.1476-5381.1963.tb01511.x.

引用本文的文献

1
The importance of plasma kinins in the anaphylactoid reaction in rats.血浆激肽在大鼠类过敏反应中的重要性。
Br J Pharmacol Chemother. 1967 Oct;31(2):331-9. doi: 10.1111/j.1476-5381.1967.tb02002.x.
2
Possible role of lecithin in the development of the slow muscle contracting activity of human plasma.卵磷脂在人类血浆慢肌收缩活性发展中的可能作用。
Br J Pharmacol Chemother. 1967 Jan;29(1):80-8. doi: 10.1111/j.1476-5381.1967.tb01941.x.
3
FURTHER STUDIES OF THE SENSITIZATION OF SMOOTH MUSCLE TO THE ACTION OF PLASMA KININS BY PROTEOLYTIC ENZYMES.关于蛋白水解酶使平滑肌对血浆激肽作用敏感化的进一步研究。
Br J Pharmacol Chemother. 1965 Apr;24(2):485-96. doi: 10.1111/j.1476-5381.1965.tb01738.x.
4
EFFECT OF MECHANICAL STIMULATION ON RABBITS' EYES: RELEASE OF ACTIVE SUBSTANCE IN ANTERIOR CHAMBER PERFUSATES.机械刺激对兔眼的影响：前房灌注液中活性物质的释放
J Physiol. 1965 Feb;176(3):378-408. doi: 10.1113/jphysiol.1965.sp007557.
5
[Recent results in the field of plasma kinins].[血浆激肽领域的近期研究成果]
Klin Wochenschr. 1963 Apr 1;41:297-311. doi: 10.1007/BF01484325.
6
The inflammatory response.炎症反应。
Bacteriol Rev. 1963 Jun;27(2):117-54. doi: 10.1128/br.27.2.117-154.1963.
7
The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.过敏性休克期间组胺的释放及慢反应物质（SRS-A）的形成。
J Physiol. 1960 Jun;151(3):416-35. doi: 10.1113/jphysiol.1960.sp006449.
8
The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig.缓激肽、血清激肽释放酶及其他内源性物质对豚鼠毛细血管通透性的影响。
J Physiol. 1960 Jun;152(1):75-86. doi: 10.1113/jphysiol.1960.sp006470.
9
Studies on the slow contraction of smooth muscle produced by human plasma.关于人体血浆引起平滑肌缓慢收缩的研究。
Br J Pharmacol Chemother. 1961 Aug;17(1):51-8. doi: 10.1111/j.1476-5381.1961.tb01103.x.
10
Bradykinin formation in human skin as a factor in heat vasodilatation.人皮肤中缓激肽的形成作为热血管舒张的一个因素。
J Physiol. 1958 Jul 14;142(2):219-32. doi: 10.1113/jphysiol.1958.sp006011.

本文引用的文献

1
[Kallikrein inactovator in potatoes].[土豆中的激肽释放酶灭活剂]
Biochem Z. 1952 May;322(6):414-7.
2
Compound 48/80: a potent histamine liberator.化合物48/80：一种强效组胺释放剂。
Br J Pharmacol Chemother. 1951 Sep;6(3):499-508. doi: 10.1111/j.1476-5381.1951.tb00661.x.
3
[Trypsin, chymotrypsin, kallidin and bradykinin].[胰蛋白酶、糜蛋白酶、胰激肽和缓激肽]
Biochem Z. 1950;321(3):213-20.
4
Bradykinin, assay of purification.缓激肽，纯化测定
Arch Biochem. 1950 Jul;27(2):410-7.
5
Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.血清中类似酶的球蛋白再现炎症的血管现象。I. 豚鼠血清中的一种可激活的通透性因子及其抑制剂。
Br J Exp Pathol. 1955 Feb;36(1):71-81.
6
[Data on the hypotensive effect of trypsin].[关于胰蛋白酶降压作用的数据]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;225(5):369-80.
7
A delayed, slow contracting effect of plasma and serum due to the formation of a substance resembling kallidin and bradykinin.由于形成了一种类似胰激肽和缓激肽的物质，血浆和血清产生延迟、缓慢的收缩效应。
J Physiol. 1955 Jul 28;129(1):30-1P.
8
Development of pain-producing substance in human plasma.人血浆中致痛物质的产生
Nature. 1954 Oct 23;174(4434):791-2. doi: 10.1038/174791a0.
9
Activation of a histamine-releasing agent (anaphylatoxin) in normal rat plasma.组胺释放剂（过敏毒素）在正常大鼠血浆中的激活。
Br J Exp Pathol. 1954 Oct;35(5):507-18.
10
The presence of histamine, 5-hydroxytryptamine and a potent, slow contracting substance in wasp venom.黄蜂毒液中存在组胺、5-羟色胺和一种强效的、作用缓慢的收缩物质。
Br J Pharmacol Chemother. 1954 Mar;9(1):53-8. doi: 10.1111/j.1476-5381.1954.tb00816.x.

A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin.

作者信息

SCHACHTER M

出版信息

Br J Pharmacol Chemother. 1956 Jun;11(2):111-8. doi: 10.1111/j.1476-5381.1956.tb01038.x.

DOI:10.1111/j.1476-5381.1956.tb01038.x
PMID:13329324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1509590/
Abstract
摘要